Oxford Immunotec Global Plc Revenue per Employee (OXFD), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Oxford Immunotec Global Plc  (NASDAQ: OXFD)
 

Oxford Immunotec Global Plc's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Oxford Immunotec Global Plc's Revenue per employee fell on a trailing twelve month basis to $ 272,838, below the company average number of $347,795.
Within the Healthcare sector Employees of 224 other companies have achieved higher revenue per employee. While Oxford Immunotec Global Plc's total ranking has deteriorated compared to the previous quarter from 0 to 2026. Oxford Immunotec Global Plc has 210 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

OXFD Revenue per Employee (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter		 (Mar 31 2020)
I. Quarter		 (Dec 31 2019)
IV. Quarter		 (Sep 30 2019)
III. Quarter
Y / Y Revenue Change -8.4 % -70.21 % -5.94 % 17.88 % 32.21 %
Sales per Employee (TTM) $ 272,838 281,329 346,819 351,000 337,919
OXFD's Total Ranking # 2026 # 0 # 0 # 0 # 0
Seq. Revenue Change 233.09 % -58.05 % -23.2 % -14.63 % 8.33 %

OXFD Company Profile >> Back to OXFD Efficiency Comparisons >> Compare OXFD Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 3
Healthcare Sector # 225
Overall Market # 2026

Revenue per Employee Statistics
High Average Low
$ 506,490 $ 347,795 $ 206,867
(Sep 30 2017)   (Jun 30 2019)



Financial Statements
Oxford Immunotec Global Plc's Revenue MRQ $ 19 Millions Visit OXFD's Income Statement
Oxford Immunotec Global Plc's Revenues TTM $ 57 Millions Visit OXFD's aggregate revenue growth
What are OXFD's Sales? Visit OXFD's Sales by Segment




Other Ratios
Oxford Immunotec Global Plc's Income per Employee
Employees in In Vitro & In Vivo Diagnostic Substances
In Vitro & In Vivo Diagnostic Substances Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
OXFD's Revenue per Employee versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for OXFD's Competitors
Revenue per Employee for OXFD's Suppliers
Revenue per Employee for OXFD's Customers

You may also want to know
OXFD's Sales Growth Rates OXFD's Pe Price to earnings ratio OXFD's Receivables Turnover Ratio OXFD's Stock Quote
OXFD's Net Income Growth Rates OXFD's Ps Price to Sales ratio OXFD's Sales per Employee OXFD's Asset Turnover Ratio
OXFD's Net Margin OXFD's Pb Price to Book ratio OXFD's Financial Strength Ratios OXFD's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:03+00:00




Companies with similar Revenue per Employee for 12 months ending Sep 30 2020, within Healthcare Sector Revenue per Employee Revenue 12 months ending Sep 30 2020Number of Employees Sep 30 2020
Vapotherm Inc   477,248.78 $ 97.836  Million 205 
Teva Pharmaceutical Industries Limited  477,054.49 $ 16,196.000  Million 33,950 
Luna Innovations Inc  476,343.27 $ 76.215  Million 160 
Halozyme Therapeutics Inc   471,763.59 $ 199.556  Million 423 
Accuray Incorporated  468,087.76 $ 378.683  Million 809 
Nature s Sunshine Products inc   465,455.33 $ 375.157  Million 806 
Cardiovascular Systems Inc   465,198.00 $ 232.599  Million 500 
Eli Lilly And Company  464,276.00 $ 23,213.800  Million 50,000 
Curis Inc   462,416.67 $ 11.098  Million 24 
Avantor Inc   453,829.63 $ 6,126.700  Million 13,500 
Vanda Pharmaceuticals Inc   452,992.50 $ 241.445  Million 533 
Elutia Inc   452,846.15 $ 11.774  Million 26 
Zoetis Inc   451,172.41 $ 6,542.000  Million 14,500 
Spero Therapeutics Inc   442,120.00 $ 11.053  Million 25 
Icad Inc  439,621.21 $ 29.015  Million 66 
Talphera Inc   429,416.67 $ 5.153  Million 12 
Fuse Medical Inc   425,944.71 $ 21.723  Million 51 
American Bio Medica Corporation  424,900.00 $ 4.249  Million 10 
Angiodynamics Inc   424,574.37 $ 268.331  Million 632 
Inogen Inc   416,236.39 $ 313.426  Million 753 
Zimmer Biomet Holdings Inc   415,582.35 $ 7,064.900  Million 17,000 
Cryo cell International Inc   415,489.34 $ 31.577  Million 76 
Pediatrix Medical Group Inc   415,122.96 $ 2,721.131  Million 6,555 
Co diagnostics Inc   413,183.66 $ 47.516  Million 115 
Harpoon Therapeutics Inc   406,200.00 $ 12.186  Million 30 
Lexicon Pharmaceuticals Inc   401,518.52 $ 32.523  Million 81 
Karyopharm Therapeutics Inc   399,478.07 $ 91.081  Million 228 
Rockwell Medical inc   398,234.62 $ 62.523  Million 157 
Bausch Health Companies Inc   395,960.59 $ 8,038.000  Million 20,300 
Cumberland Pharmaceuticals Inc   392,313.47 $ 36.485  Million 93 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.